We are looking for volunteers to take part in the CORSER-5 study. The study was launched in March 2022 to compare the immunity of COVID-19-positive individuals at the very beginning of their infection period ("cases") with that of non-infected individuals ("controls").
The results could be used to establish a booster vaccination strategy for SARS-CoV-2 on the basis of patients' antibody levels..
We are currently looking for "controls":
- who can travel to the Institut Pasteur (Paris, 15th arrondissement)
- and who have not been infected with SARS-CoV-2 for at least 3 months.
Interested? Go to the page CORSER 5 - Research - Institut Pasteur (in French)
The team in charge of the CORSER-5 study has been working in recent months to develop a better understanding of COVID-19. The same research unit also coordinates the COMCOR epidemiological study, which was launched in October 2020. The initial aim of the COMCOR study was to identify the socio-demographic factors, places visited and behaviors associated with a higher risk of infection with SARS-CoV-2.
More than 750,000 participants have been recruited to date and the analysis of their responses to the questionnaire has led to the publication of three articles in the scientific journal The Lancet Regional Health Europe and more recently a fourth article in the journal Clinical Microbiology and Infection.
Two further articles about the incubation period for different variants and the use of self-tests by the general population are currently under peer review prior to publication.
By participating in CORSER-5, you will be helping to improve scientific knowledge, like the participants in COMCOR.
See also the report ComCor: results and critical analysis of the study on places and circumstances of SARS-CoV-2 infection (pasteur.fr) (in French)